CAS: 72300-69-7; (R)-Pyrrolidin-2-Ylmethanamine

该化合物是一种有机化合物,其特点是五人环状结构,即五人环状矿,具有一种有矿功能的组,有助于其基本性和反应性.这是一种手性分子,其(R)配置表明其原子的特定空间安排,可影响其生物活动和相互作用.一般而言,(2R)-2-Pyrrolinemethanine是一种无色的黄色液体或固体,取决于其形式和纯度.它溶于水和各种有机溶剂中,可溶于水和各种有机溶剂,可适用于不同的用途.该化合物经常用于合成药物和农用化学,以及研究矿的再活性和气性.安全数据表明,与许多氨一样,应对该物质的处理应注意潜在的刺激性.

结构式图片

相似化合物

119020-01-8 177911-87-4 259537-92-3

欧盟法规

C&L通报REACH预注册

上下游产品

(R)-prolinamide Z-D-proline D-Prolin (2R)-2-carbamoyl-pyrrolidine-1-carboxylic acid benzyl ester (4aS,13aR)-8-bromo-10-[(phenylmethyl)oxy]-2,3,4a,5,13,13a-hexahydro-1H-pyrido[1,2-a]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazine-9,11-dione N-[((2R)-1-{[3,4-bis(methyloxy)phenyl]sulfonyl}-2-pyrrolidinyl)methyl]-3,4-bis(methyloxy)benzenesulfonamide N-[((2R)-1-{[3,4-bis(methyloxy)phenyl]sulfonyl}-2-pyrrolidinyl)methyl]-3,4-bis(methyloxy)benzenesulfonamide

合成工艺路线路线简述

    📜(R)-2-(氨甲基)-1-Boc-吡咯烷置于盐酸,水体系中,用 四氢呋喃,甲醇,二氯甲烷 作为反应溶剂,化学反应 1.0H,以100%的收率获得产物(R)-2-(氨甲基)吡咯烷
    参考文献:Wo2006/116764
    标题:Wo2006/116764

    海关参考信息

    专利信息


    专利号:US-5468876-A
    优先权日:1986-05-22
    标题:Intermediates for the stereoconservative synthesis of 1-substituted (S)-and (R)-2-aminomethylpyrrolidines
    发明人:FEDERSEL HANS-JUEGEN; HOE THOMAS; RAEMSBY STEN I; STROEM PETER H E
    权利人:ASTRA AB
    摘要:Disclosed are (R)- and (S)-isomers of the compounds of the Formulas II and III with at least 95% optical purity ##STR1## wherein R 1 and R 2 are the same or different and represent a hydrogen atom, a lower alkyl, lower alkenyl or lower alkynyl group, a cycloalkyl group or a group (CH 2 ) m Ph, wherein m is 0-3 and Ph is a substituted or unsubstituted phenyl group. n These compounds are intermediates in the stereoconservative synthesis of 1-substituted (S)- and (R)-2-aminomethylpyrrolidines.

    专利号:US-9365587-B2
    优先权日:2008-12-11
    标 题:Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
    发明人:YOSHIDA HIROSHI; TAODA YOSHIYUKI; JOHNS BRIAN ALVIN; KAWASUJI TAKASHI; NAGAMATSU DAIKI
    权利人:SHIONOGI & CO; VIIV HEALTHCARE CO
    摘要:The invention is a process for the preparation of a compound of the following formula (I): n nwherein R is —CHO, —CH(OH) 2 or —CH(OH)(OR 4 ); P 1 is H or a hydroxyl protecting group; P 3 is H or a carboxy protecting group; R 3 is H, halogen, hydroxy, optionally substituted lower alkyl, optionally substituted cycloalkyl, etc.; R x is H, halogen or R 2 —X—NR 1 —C(O)—; etc. as defined in the specification. The compounds are useful as intermediates in synthesizing compounds having HIV integrase inhibitory activity.

    专利号:WO-2019012000-A1
    优先权日:2017-07-12
    标题:NEW SYNTHESIS OF INTERMEDIATES FOR THE PREPARATION OF ALPHA-TOCOPHEROL

    专利号:WO-8707271-A1
    优先权日:1986-05-22
    标 题 :A stereoconservative synthesis of 1-substituted (s)- and (r)-2-aminomethylpyrrolidines and intermediates thereto

    专利号:US-8754214-B2
    优先权日:2008-12-11
    标题 :Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates

    专利号:FI-880265-A7
    优先权日:1986-05-22
    标题 :Efficient stereostructure preserving synthesis of 1-substituted (S)- and (R)-2-aminomethylpyrrolidines and their intermediates

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/bf00210782
    摘要:Stewart DJ, Raaphorst GP, Yau J, Beaubien AR. Active vs. passive resistance, dose-response relationships, high dose chemotherapy, and resistance modulation: a hypothesis. Invest New Drugs. 1996;14(2):115–30. doi: 10.1007/bf00210782.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知